Related Experiment Video
Updated: Feb 13, 2026

Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring
Published on: November 13, 2012
NanoTRAIL-Oncology: A Strategic Approach in Cancer Research and Therapy
Yesi Shi1, Xin Pang1, Junqing Wang1,2
1State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics and Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen, 361102, China.
Abstract:
TRAIL is a member of the tumor necrosis factor superfamily that can largely trigger apoptosis in a wide variety of cancer cells, but not in normal cells. However, insufficient exposure to cancer tissues or cells and drug resistance has severely impeded the clinical application of TRAIL. Recently, nanobiotechnology has brought about a revolution in advanced drug delivery for enhanced anticancer therapy using TRAIL. With the help of materials science, immunology, genetic engineering, and protein engineering, substantial progress is made by expressing fusion proteins with TRAIL, engineering TRAIL on biological membranes, and loading TRAIL into functional nanocarriers or conjugating it onto their surfaces. Thus, the nanoparticle-based TRAIL (nanoTRAIL) opens up intriguing opportunities for efficient and safe bioapplications. In this review, the mechanisms of action and biological function of TRAIL, as well as the current status of TRAIL treatment, are comprehensively discussed. The application of functional nanotechnology combined with TRAIL in cancer therapy is also discussed.
Insights
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) shows promise for cancer therapy. Nanobiotechnology enhances TRAIL delivery, overcoming limitations for improved anticancer treatments.
Area of Science:
- Biotechnology
- Nanomedicine
- Cancer Biology
Background:
- TRAIL induces apoptosis in cancer cells but faces challenges like limited exposure and drug resistance.
- Clinical application of TRAIL is hindered by these significant obstacles.
- Nanobiotechnology offers novel solutions for enhanced drug delivery in cancer therapy.
Purpose of the Study:
- To review the mechanisms and biological functions of TRAIL.
- To discuss the current status of TRAIL-based cancer treatments.
- To explore the application of nanotechnology with TRAIL for advanced cancer therapy.
Main Methods:
- Review of existing literature on TRAIL and nanobiotechnology.
- Analysis of strategies for TRAIL delivery, including fusion proteins, membrane engineering, and nanocarriers.
- Discussion of nanoparticle-based TRAIL (nanoTRAIL) applications.
Main Results:
- Nanobiotechnology enables improved expression, targeting, and delivery of TRAIL.
- Functional nanotechnology combined with TRAIL shows potential for enhanced anticancer therapy.
- nanoTRAIL presents opportunities for efficient and safe bioapplications.
Conclusions:
- Nanotechnology significantly advances TRAIL-based cancer treatment strategies.
- nanoTRAIL offers a promising platform for overcoming TRAIL's clinical limitations.
- Further research in functional nanotechnology is crucial for optimizing nanoTRAIL therapies.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Strategies of Self-Presentation I: Strategic Self-Presentation
Gene Therapy
Group Therapy
Frustration and Conflict: Approach-Approach, Approach-Avoidance
One common type of conflict is the Approach–Approach Conflict. In this case, a person faces two desirable...

